Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

May 31, 2006

Conditions

AnemiaKidney Failure, ChronicPeritoneal Dialysis, Continuous Ambulatory

Interventions

DRUG

Darbepoetin alfa

Trial Locations (1)

Princess Margaret Hospital, Hong Kong

All Listed Sponsors

collaborator

Kirin Pharmaceutical (Asia) CO., LTD

UNKNOWN

lead

Hospital Authority, Hong Kong

OTHER_GOV

NCT00563446 - Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia | Biotech Hunter | Biotech Hunter